ChartSpan Medical Technologies Inc. acquires Validic Inc.

ChartSpan Medical Technologies Inc., an integrated care management company based in the United States, has acquired Validic Inc., a digital health data platform provider also headquartered in the US. The deal closed on June 16, 2026, and was announced publicly on June 30, 2026. Oppenheimer & Co. served as exclusive financial advisor to Validic in this transaction.

Deal Mechanics

The acquisition of Validic by ChartSpan consolidates two players within the digital health sector. With this move, ChartSpan aims to bolster its remote care management offerings through integration with Validic's comprehensive data platform.

Strategic Rationale

This transaction represents a strategic alliance that leverages ChartSpan's extensive experience in care coordination and population health services alongside Validic's cutting-edge capabilities in aggregating, analyzing, and delivering actionable insights from patient-generated health data. The combined entity will be well-positioned to address the growing demand for remote monitoring solutions within the healthcare industry.

Financial Context

Terms of the acquisition were not disclosed by either party involved in the transaction. However, ChartSpan is expected to finance this deal through a combination of cash on hand and potential debt financing from financial institutions.

Advisors

No buy-side advisors or legal counsel for either ChartSpan or Validic was announced at the time of closing. Oppenheimer & Co., however, took an active role in providing exclusive financial advisory services to Validic during negotiations and due diligence processes leading up to this agreement.

Outlook

The integration of Validic's platform into ChartSpan's service suite is anticipated to enhance patient engagement and outcomes while reducing overall healthcare costs. As a result, both companies are optimistic about the future growth potential of their combined solution in the digital health market.